ReoPro and Retavase to Restore Brain Blood Flow After Stroke
NCT00039832
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
42
Enrollment
NIH
Sponsor class
Conditions
Cerebrovascular Accident
Interventions
DRUG:
Abciximab (ReoPro) and Reteplase (Retavase)
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)